Ausgabe Sonderheft 1/2014
Antibodies: Molecules, Receptors, Functions, and Therapeutic Usage
Inhalt (20 Artikel)
Natural Autoantibodies to Fcγ Receptors in Intravenous Immunoglobulins
Hicham Bouhlal, Denis Martinvalet, Jean-Luc Teillaud, Catherine Fridman, Michel D. Kazatchkine, Jagadeesh Bayry, Sébastien Lacroix-Desmazes, Srini V. Kaveri
Natural IgM: Beneficial Autoantibodies for the Control of Inflammatory and Autoimmune Disease
Caroline Grönwall, Gregg J. Silverman
Natural IgM Anti-leucocyte Autoantibodies (IgM-ALA) Regulate Inflammation Induced by Innate and Adaptive Immune Mechanisms
Peter I. Lobo, Kenneth L. Brayman, Mark D. Okusa
The Long Elusive IgM Fc Receptor, FcμR
Hiromi Kubagawa, Satoshi Oka, Yoshiki Kubagawa, Ikuko Torii, Eiji Takayama, Dong-Won Kang, Dewitt Jones, Naonori Nishida, Toshio Miyawaki, Luigi F. Bertoli, Sheila K. Sanders, Kazuhito Honjo
Role of FcγRIIIA (CD16) in IVIg-Mediated Anti-Inflammatory Function
Sanae Ben Mkaddem, Meryem Aloulou, Marc Benhamou, Renato C. Monteiro
Janus Faces of Amyloid Proteins in Neuroinflammation
Lawrence Steinman, Jonathan B. Rothbard, Michael P. Kurnellas
Intravenous Immunoglobulin (IVIG) Treatment Exerts Antioxidant and Neuropreservatory Effects in Preclinical Models of Alzheimer’s Disease
Scott E. Counts, Balmiki Ray, Elliott J. Mufson, Sylvia E. Perez, Bin He, Debomoy K. Lahiri
Molecules Involved in the Crosstalk Between Immune- and Peripheral Nerve Schwann Cells
Nevena Tzekova, André Heinen, Patrick Küry
MMN: From Immunological Cross-Talk to Conduction Block
Oliver Harschnitz, Bas A. Jongbloed, Hessel Franssen, Dirk C. G Straver, W. Ludo van der Pol, Leonard H. van den Berg
Treatment of Spinal Cord Injury with Intravenous Immunoglobulin G: Preliminary Evidence and Future Perspectives
Apostolia Tzekou, Michael G. Fehlings